FDA Approved: OXALIPLATIN — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)

View source ↗

Summary

The FDA approved a supplemental application for the generic oxaliplatin product submitted by Qilu Pharmaceutical Co., Ltd. under ANDA204368.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)